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Summary During our studies of DNA fingerprinting of tumours of the pancreas and papilla (ampulla) of Vater, using arbitrarily primed
polymerase chain reaction (AP-PCR), we noticed two bands showing a decreased intensity in six of ten ampullary tumours with respect to
matched normal tissues. Those bands were both assigned to chromosome 5. Such afinding was somewhat in contrast with the reportedly low
frequency of APC gene mutations in ampullary cancers, located at chromosome 5q21, and suggested that loci different from that of APC
might be the target of chromosome 5 allelic losses (LOH) in these tumours. Therefore, we analysed chromosome 5 LOH in a panel of 27
ampullary tumours, including eight adenomas, four earty- and 15 advanced-stage cancers, using 16 PCR-amplified CA microsatellite
polymorphic markers spanning the entire chromosome. Nineteen cases (70%/a) showed LOH, and the interstital deletions found in these
tumours described two smallest common deleted regions, in which putative suppressor genes might reside. They were at 5q13.3-q14 and at
5q23-q31 respectively, which correspond to those found in gastic tumours. In additon, the presence of 5q LOH in six of eight adenomas and
in three of four earty-stage cancers suggests that such phenomena occur at earty stages of neoplastic progression of the ampullary
epithelium.
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It is widely accepted that accumulation of genetic changes under-
lies the development of cancer. However. there is evidence that it
is not simply the accumulation of mutations. but also their order.
that determines the propensity for neoplasia. and that only a subset
of the genes that can affect cell growth can actually initiate the
neoplastic process (Kinzler and Vogelstein. 1996). Progress in
understanding the pathogenesis of different malignancies will in
large part depend on identifying the early genetic anomalies
involved in the initiation ofneoplastic transformation. The earliest
genetic event in the great majority of colorectal cancers is inacti-
vation of the adenomatosis polyposis coli (APC) gene (Jen et al.
1994). However. APC gene mutation seems not to be a step-
limiting event ofneoplastic progression in gastrointestinal cancers
other than colorectal. In fact.APC mutations are infrequent in oral.
oesophageal. gastric. pancreatic and liver cancer. and. with the
possible exception of Ki-ras mutations in pancreatic cancer. the
earliest genetic alteration in these malignancies has not yet been
discovered (Honi et al. 1992a: b; McKie et al. 1993; Ogasawara et
al. 1994: Powell et al. 1994: Seymour et al. 1994: Uzawa et al.
1994; Yashima et al. 1994: Hahn et al. 1995).
During our studies of DNA fingerprinting of cancers of the
pancreas and of the papilla (ampulla) of Vater. using arbitrarily
primed polymerase chain reaction (AP-PCR). we noticed two
bands showing a decreased intensity in six of ten ampullary
tumours. including one adenoma. with respect to matched normal
tissues. It has been demonstrated that decreased intensity of
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AP-PCR bands in tumour DNA reflects allelic losses. whereas
increased band intensity indicates the presence of extra copies of
these sequences (Achille et al. 1996a; Peinado et al, 1992). The
two AP-PCR bands were both assigned to chromosome 5. Such
information led us to analyse the entire chromosome 5 for the
presence ofallelic losses (LOHs) in a panel ofampullary tumours.
in addition to the fact that our previous observation of a low
frequency ofAPC gene mutations in these cancers (Achille et al.
1996b) suggested that theAPCgene. located at chromosome 5q21,
might not be the exclusive or most important target of chromo-
some 5 deletions in ampullary tumours. In this respect. it is worthy
of note that no structural abnormality of chromosome 5 had been
reported in the nine ampullary or periampullary carcinomas in
which cytogenetic analysis was performed (Johansson et al. 1992:
Bardi et al. 1993. 1994). Molecular techniques are more sensitive
than cytogenetic analysis in detecting loss of genetic material.
wherever it is located. either in its natural position or in the context
of complex translocations. and in determining the smallest
common deleted regions (SCDRs) involved in those alterations.
These methods are based on the detection ofLOH at chromosome-
specific polymorphic sites in DNA extracted from tumour, when
compared with DNA from matched normal tissues. Such 'allelo-
typing' is feasible by PCR amplification of microsatellite repeats.
provided the heterozygosity for the studied loci and neoplastic
cellularity are higher than 50-60% in the cancer sample (Louis et
al. 1992).
We explored chromosome 5 LOH in 27 ampullary tumours,
including eight adenomas. using PCR amplification of matched
normal and cancer DNAs with a set of CA microsatellite repeat-
specific primers. Our results indicate that chromosome Sq LOH is
frequent (70%) in ampullary tumours, and point to the presence of
two different SCDRs. away from the APC locus and similar to
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Table 1 CliniKopathogical data and results of chromosome 5 allelotyping listed according to the stage of the disease
Case Sex Age Diagno Size Gradec Staged APC Chromoso 5
(cm) mutatKon LOH
Frozen samples
AT 11 M 70 Adenomna 2 - - No Yes
AT 9 M 53 Adenoma 2 M Yes No
AT 17 F 57 Adenomna 5 W II Yes Yes
AT 10 M 66 Papillary carcinoma 2 M II No No
AT 2 M 59 Carcinoma with adenoma 1.5 P II No Yes
AT 24 M 35 Carcinoma with adenoma 2 P II No Yes
AT 14 M 48 Carcinoma with adenoma 2 M IlIl Yes Yes
AT 4 M 66 Caranona with adenoma 1.5 P IV No Yes
AT 18 M 36 Carcinomawithadenoma 1.5 P IV No Yes
AT 27 M 69 Carcinoma wih adenoma 3 M IV No Yes
AT 20 F 59 Papillary carcinoma 2 M II N No No
AT 15 M 44 Carcinoma with adenorna 1.8 P III N No Yes
AT 3 M 73 Carcinoma 2 M III N No No
AT 29 M 62 Carcinoma 2 M/P III N No Yes
AT 22 M 53 Carcinoma 3 M IlIl N No No
AT 5 M 57 Carcinoma with adenoma 2.5 P IV N No Yes
AT 12 M 37 Carcinomawith adenoma 1.5 P IV N No Yes
AT 1 F 70 Carcinoma 3.5 M IV N No Yes
AT 16 M 49 Carcinoma 1 P IV N No No
AT 19 M 64 CoJloid carcinoma 7 - IV N Yes Yes
AT 8 M 62 Neuroendocrine caranoma 2 - IV N No No
AT 13 F 60 Carcinomawith adenoma 2 P IV N No Yes
Paraffin samples
pAT 1 M 60 Adenoma 1.2 - - ND Yes
pAT 2 M 55 Adenona 1.5 - - ND Yes
pAT 3 M 67 Adenoma 2 - - ND Yes
pAT 4 M 74 Adenomna 2 - - ND Yes
pAT 5 M 79 Adenoma 3 - - ND No
aCases from AT1 to AT18 have been previously reported for APCmutations and LOH limited at band q21 of chromosome 5 (Achille et al, 1996b). tAdenornas
AT9 and AT17 had cancer foci. However, the molecular analysis of these cases was performed only on the adenoma component (see Materias and methods).
NW, well dferentiated; M, moderately differentiated; P, poorly differentiated. dl, intaductal; II, infiltration of duodenal submucosa; III, involvement of duodenal
muscularis propria; IV, infiltraton of periduodenal fat and pancreas. N, nodal metastases. eND, not done in cases from paraffin-embedded tissues.
those found in gastric cancer. In addition. thefinding that six ofthe
eight adenomas showed 5q LOH suggests that they occur at early
stages ofneoplastic progression ofthe ampullary epithelium.
MATERIALS AND METHODS
A panel of 27 tumours of unequivocal origin from the anatomical
structures of the papilla of Vater. collected at the Pathology
Department of the University of Verona. Italy. was studied. The
panel included 19 carcinomas and three adenomas for which
frozen samples were available. and five adenomas from formalin-
fixed paraffim-embedded samples (Table 1). Matched normal
tissue was available in all cases.
The high molecularweight DNA from frozen tissues was exten-
sively studied by AP-PCR and chromosome 5 allelotyping. The
study on the partially degraded DNA from the paraffm-embedded
tissues was limited to the analysis of chromosome 5 aHlelic losses
at the hot spots resulting from the analysis offrozen tissues.
Adequacy of tissue samples and DNA extraction
Samples were selected on the basis of the availability of a
neoplastic cellulanrty of more than 60% in tumour specimens.
which is crucial for loss of DNA sequences to be detectable when
compared with matched normal tissues. For this purpose.
neoplastic cellularity was assessed on stained slides prepared
during the cryostat dissection or from paraffin sections and was a
conservative estimate of the number of neoplastic cells as a
percentage of total cells in the final sample. The neoplastic popu-
lation was enriched by either eliminating the portions of normal
tissue from the frozen or paraffin blocks or scraping neoplastic
areas from slides. A neoplastic cellularity ranging from 70% to
90% was obtained in 19 cases. and ofabout 60% in cases AT3 and
ATI2. DNA was prepared as described (Achille et al. 1996b).
From the 34 initiaHly available frozen samples. seven tumours
were excluded from the study because ofthe impossibility ofcryo-
stat enrichment for the low cancer cellularity in two cases and the
presence of microsatellite instability ofthe type seen in hereditary
non-polyposis colorectal cancer in the other five cases (Aaltonen
et al. 1993: Ionov et al. 1993: Achille et al. 1997). In addition. the
carcinomatous component oftwo adenomas. AT9 and AT17. could
not be enriched because of its scarcity. Therefore. only the adeno-
matous component could be enriched for LOH analysis in these
two cases.
AP-PCR
Ten ampullary tumours. including eight cancers and two
adenomas. were studied by AP-PCR as part of a larger survey on
different pancreatic and periampullary tumours. The eight cancers
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Table 2 Cumulative resutts of chromosome 5 LOH in 22 cases of frozen
prinary ampulary cancer
Marker Location Inormative Cancer Frequency
cas (%) with LOH of LOH (%)
D5S392 5p15.33 20 (91) 3 15
D5S406 5p15.32 16 (73) 1 6
D5S108 5p14.1-p13.1 12 (55) 1 8
D5S419 5p12.1 17 (77) 4 23
D5S76 5cen-q11.2 18 (82) 7 39
D5S107 5q11.2-q13.3 16 (73) 5 31
D5S428 5q13.3-q14 17 (77) 9 53
D5S409 5q14-.q21 12 (55) 5 42
D5S82 5q15-q23 14 (65) 6 43
D5S346 5q21-q22 19 (82) 7 37
D5S299 5q15-q23 12 (55) 6 50
FBN2 5q23-q31 14 (64) 9 64
IRF1 5q23-q31 14 (64) 10 71
D5S178 5q31 18 (82) 7 39
D5S209 5q31.1-q33.3 15 (68) 7 47
D5S210 5q31.3-q33.3 17 (77) 5 29
were AT2. AT3. AT5. AT14. AT15. AT20, AT22 and AT29: the two
adenomas were ATI1 and AT17. The arbitrary primer used was
AR3. 5'-GCGAATTCATGTACGTCAGG-3'. DNA (70 ng) was
incubated with 0.6 units of Taq Polymerase (Perkin-Elmer/
Cetus) 125 muL each dNTP, 0.13 p1 of [a-32P]dCTP (Amersham.
3000 Ci mmol-'), 10 Im Tris-HCI pH 8.2, 50 inrL potassium chlo-
ride, S mm magnesium chloride. 0.1% gelatin and arbitrary primer
(0. Imm) in a final volume of 15 jl. The reactions were carried out
in a thernal cycler (PT-100. MJ Research) for five cycles at low
stringency (94°C for 30 s. 50°C for 1 mn, and 72°C for 1.5 min)
and 25 cycles at high stringency (94°C for 15 s. 60°C for 15 s and
72°C for 1 min). An aliquot of 5 1l of the AP-PCR product was
diluted in 13 p1 of dilution loading buffer (0.01% of each
bromophenol blue and xylene-cyanol. 0.01 N sodium hydroxide.
0.1 M EDTA, 93% formamide), and 3 p1 electrophoresed in a 5%
polyacrylamide gel containing 8 M urea set up by wedge spacers
(0.4-1.2 cm). After electrophoresis, the gel was transferred on to
filter paper, dryed under vacuum and exposed for multiple times.
ranging from 12 to 24 h, to X-ray films (Kodak X-Omat AR). Each
experiment was performed in triplicate.
Chromosomal assignment of bands A and G of AR-3
AP-PCR fingerprint
To determine the chromosomal localization ofbands A and G (see
results). we used the same AR-3 prinmer to amplify. with the same
AP-PCR protocol described above, the DNA (70 ng) from each of
the 24 monochromosomal hybrids included in the human-rodent
somatic cell hybrid panel no. 2 (Drwinga et al, 1993). Hamster and
mouse DNAs were used as controls. The chromosomal assignment
wasaccomplished bycomparing the human fingerprints with those
obtained from each monochromosomal hybrid. as described previ-
ously (Achille et al. 1996a; Yasuda et al, 1996).
To confirm the assignment ofbands A and G, the simultaneous
hybridization of AP-PCR DNA fingerpnrnting product (SHARP)
analysis was used (Yasuda et al. 1996). In this method. DNA
fingerprints generated from human-rodent monochromosome cell
hybrids are electroblotted on to a nylon membrane and hybridized
to radioactively labelled human AP-PCR products obtained with
AT3 AT2 AT5 AT20 AT22
I . . SY 1
N T aN T N T N T N T
- Band A
0
- Band G
Figure 1 AP-PCR analysis of ampullay tumours with AR-3 arbitrary primer.
A porion of te gel including bands A and G is shown. The cosed arcle
indicate ano-polyophic doUble band that has been used as an intemal
control of DNA content in each lane, as its intensity was proporbonal to the
concentration of template DNA used in multiple AP-PCR experiments of
cdfferent samples. N and T ndicate normal and cancer DNA respectively.
Bands A and G show a reduced intensity (arrowheads) in cancers AT5 and
AT2 when compared with theircorrespondig nrma DNA, which was
confirmed in replcate experinents. Cancers AT20 and AT22 show a clear
increase in intensity of band A, suggestn the presence of extra coples of
the amplfied chromosomal DNA sequences, whereas the diminished
intensity of band A in cancer AT3 was not confirmed in replicate AP-PCR
experiments
the same arbitrary primer. Human-specific hybridization bands in
the human-rodent fingerprints unambiguously determine their
chromosome origin. Briefly. the blotted fingerprinting membrane
was hybridized at 42°C for 12-16 h in hybridization buffer [10%
dextran sulphate, 50% formamide, 50 mm Pipes (pH 7.6). 0.1%
sodium dodecyl sulphate (SDS). 50 mM EDTA and 100 ig ml'
denatured sonicated salmon testis DNA] with probe. The probe
was the entire AP-PCR product (75 ng) obtained from genomic
DNA of a human male using AR3 primer and non-radiolabelled
nucleotides as substrates. which was labelled by random prnming
using Prime-it-H Kit (Stratagene) in the presence of 150 jiCi of
[a-32P]dCTP. The filter was then washed under stringent condi-
tions (0.1 x SSC and 0.5% SDS at 550C for 20 mmn) three times
and exposed to XAR-5 films at -70°C with an intensifying screen
for 6-16 h.
Chromosome 5 allelic losses
DNAs from frozen samples were examined with 16 microsatellite
repeats from chromosome 5 by denaturing polyacrylamide gel
electrophoresis of PCR amplified loci. Of these 16 markers. four
were located on the short arm (p) and 12 on the long arm (q) (Table
2). LOH study in paraffin-embedded adenomas was performed
only at specific chromosomal loci. including D5S82 and D5S299
for chromosome 5q21. D5S428 for 5ql3.3-ql4. and FBN2 and
IRF1 for 5q23-q31. All appropriate primers for amplification of
microsatellites were purchased from the MapPairs collection
(Research Genetics. Huntsville. AL. USA). They were used at the
annealing temperature indicated by the manufacturer when using
high-quality DNA from frozen tissues and at SoC lower when
using DNA from paraffin-embedded tissues.
The reaction mixture (10gl) contained 20 ng ofgenomic DNA,
the proper pair of each primers (0.5 g.M), 125 jLM of each deoxy-
nucleotide triphosphate. lx PCR buffer (10 mM Tris-HCI pH 8.2.
1.5 mm magnesium chlonrde. 50 mm potassium chloride, 0.1%
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Figure 2 Chronosomal localization of AP-PCR bands A and G, using PCR
amplificaton with AR-3 pnmer of DNA from 24 monochromosomal
human-rodent somatic cell hybrids. Numbers identify the human
chromosome contained in each hybnd. Hamster and mouse DNAs were
used as controls. The bands corresponding to human AP-PCR bands A and
G are visible only in the lane of the hybrid containing chromosome 5
(arrowheads). Also note that the stronger band below A may be assigned to
chromosome 1
gelatin). 0.1 .tl (0.5 U) of Taq polvmerase (Perkin-Elmer/Cetus)
and 0.1 ig of [a-2'P]dCTP (3000 Ci mmol-'. Amersham). An
aliquot of 5 gl of the reaction products was diluted 1:10 with DLB
(0.05% each of bromophenol blue and xylene-cvanol. 0.01 N-
sodium hydroxide. 0.02 m EDTA and 95% formamide). denatured
and 3 jil electrophoresed for 2-3 h according to the length ofampli-
fied fragments at 60 W in 6% polyacrylamide (5% cross-linker. 0.4
mm thick) gel containing 8 M urea. Before loading, the gel was pre-
run for 30 min at 60 W. After electrophoresis the gel was fixed on
paper. dried under vacuum and exposed to X-ray film (Kodak X-
Omat AR) for various times at room temperature.
Only patients heterozygous for a given DNA sequence were
considered to be infonnative. w-hereas the presence of either
homozvoositv or unclear distinction between patemal and matemal
alleles were considered as uninformative. Allelic losses were scored
when there was loss of intensity of one allele in the tumour sample
with respect to the matched allele from normal tissue. and when the
relative intensitv ofthe tuwo alleles in the tumour DNA differed from
0
Figure 3 The assignment of AP-PCR bands A and G to chromosome 5 (see
Figure 2) was confirmed by SHARP analysis. Numbers identify the human
chromosome contained in each hybrid. Hamster and mouse DNAs were used
as controls. The bands corresponding to human AP-PCR bands A and G are
visible only in the Lane of the hybrd containing chromosome 5 (arrowheads)
that of the non-neoplastic tissue DNA by a factor of at least 1.5
(Achille et al. 1996a). The intensitx of the signal between the
different alleles was evaluated, using multiple exposure times. by
visual examination by three independent reviewers. and quantified
by densitometry (GS-670 scanning densitometer. equipped with
Molecular Analysis software. Bio-Rad. Hercules. CA. USA). The
results of allelic losses were considered reliable only ifreproducible
in replicate experiments performed by two independent researchers.
The percentage of LOH was expressed as the number of cases in
which LOH was exhibited over the number ofheterozygotes for that
particular sequence.
Mutations of the APC gene
Truncating mutations of the APC gene were searched only in
frozen samples by the APC-protein truncation test (PTT) analvsis
of codons 654-1700. and by single-strand conformation poly-
morphism (SSCP) of PCR-amplified DNA codons 279-1588. as
previously described in detail (Achille et al. 1996b).
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Fxjure 4 Analysis of four PCR amfplified rnicrosatelite koc, spannin
chromosomew 5q23-q33.1, in four primary amspulary cancers (AT1, AT2,
AT18, AT19). Alelic losse were evaluated in tumou MU when compared
with matchled normnal tisu (N) DNA. In AT1, the losses of the uppe IRFi
and of fth lower D5S178 allele are visIAe, whereas the FBN2 and D5209
were considered no-nomtv.AT2 shows lossies in all four loci. In case
AT18 the losses of the uppe allele in FBN2 and otthe lower allele in IRFi
are evident, whereas the D5S209 locus is not informativ and D5S178
shows no loss. AT19 lost the upper allele at D5S209 locus. In ftbs caethere
were no losses at IRFi and D5S178 locd, whereas FBN2 was not informativ
RESULTS
The clinicopathological characteristic ofpatients and the results of
chromosome 5 allelotyping are summnarized in Table 1.
AP-PCR
Among the consistent abnormalities noticed in replicate experi-
ments of AP-PCR fingerprints of ampullary cancers, two non-
polymorphic bands, named A and G. showed a decrease in
intensity in 60% ofcases, including five cancers (AT2, AT5, AT14.
AT15 and AT29) and one adenoma (AT17) (Figure 1). No change
in band A and G intensity was consistendly seen in cancer AT3 and
in adenoma ATIl, whereas cancers AT20 and AT22 showed an
increase in the intensity ofband A.
Chromosomal lcalzation of bands A and G by AR-3
AP-PCR fingerprint
The PCR amplification with AR-3 primer of DNA from mono-
chromosomal human-rodent cell hybrid panel no. 2 allowed the
assignment of bands A and G to chromosome 5 (Figure 2). Such
assignment was confirmed by SHARP analysis (Figure 3).
Chromosonm 5 allebtyping in frozen samples
We used 16 PCR-amplified microsatellite repeats to screen DNA
from 22 ampullary frozen tumours for LOH on chromosome 5.
The approximate position of the markers and cumulative results
are reported in Table 2. Representative results are shown in
Figures 4 and 5, in which examples ofinterpretation ofresults are
also detailed. Insights concerning the losses in positive-scoring
cases are given in Figure 6. Chromosome 5 allelic losses were
found in 15 of the 22 frozen tumours (68%). All losses included
the long arm, whereas the loss ofthe short arm was present in the
four cases with the largest chromosomal deletions. In particular.
the occurrence oflosses at all informative markers on p and q arms
suggests a reduction to monosomy in cancers AT2 and ATS.
whereas case ATl showed the loss of the entire chromosome
except the 5q21 region. Of the two adenomas showing Sq LOH,
AT17 had a large Sq deletion not including the 5q21 region where
D5S82 marker is located, whereas ATl showed an interstitial
deletion spanning Sqcen-ql4 with retention of heterozygosity at
all 5q21 markers. No case showed allelic losses on the p arm
alone. Finally, seven cases appeared to retain both copies ofchro-
mosome 5. No significant correlation was found between allelic
loss ofchromosome 5, cancer morphology and clinicopathological
data ofthe patients analysed.
Overlapping of the deletions of the cases showing interstitial
losses indicated two smallest common deleted regions (SCDRs)
D5S428
1 2 3 4 5 8
NT NT NT NT NT NT
9 11 13
NT NT NT
14 15 16 17 18 19 29 22 24
NT NT NT NT NT NT NT NT NT
Figre 5 Analy of marker D5S428, spaing chromosome 5q13.3-q14, in l8 ampulary tuxnours. Case numbers correspond to those of the tables. T is the
tunour and N the natched normal tissue DNA. In AT17 the loss of the upper alele is evident whereas in tumours 1, 2, 11, 14, 19 and 24 the ower alle is lost
Cases 3, 4, 9, 13, 16 and 22 show no osses. Cases 5, 8, 15, 18 and 29 were considered non-io
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SCDR1 and SCDR2 respectively. Adenoma pAT3 had losses at all
three regions analysed. Adenoma pAT4 lost both SCDRs. whereas
adenoma pAT5 did not show any loss. The results are detailed in
Table 3.
n ^ n O9 0
Figure 6 Delebons suggested by the allee lsses. Open columns, region is
retained; shaded columns, loss or reduction in homozygosity of the region.
The length of any column is arbirary as we possess no exact informabon of
te precise limits of a determinate deleton. Closed, LOH; open circles, both
allees are retained; thick nmmed open arcles, non-informative oci. The
smallest common deleted regions (SCDRs) obtained by this analysis are
indicated on th-e right Case numbers are indicated at the top of each column
Table 3 Ghromnosome 5q LOH anaysis in paraffin-embedded adenomas
Case SCDR1 APC SCDR2
IRFI FBN2 D5S82 D5S299 D5S428
pAT 1 Yes NI No NI No
pAT 2 NI No No No Yes
pAT 3 Yes NA NI Yes Yes
pAT 4 Yes Yes NI No Yes
pAT 5 No NI No No NI
SCDR, smallest common deleted region (see Figure 6). NI, not informative;
NA, not amplified.
(Figure 6). The first SCDR corresponds to chromosomal region
5q13.3-q14. and is descnrbed by cases AT17. AT1. AT27 and AT 11
in its lower limit. and by AT12. ATl9 and AT24 in its upper limit.
The second SCDR includes IRFl and FBN2 loci spanning the
region 5q23-q31. which was lost in 10 of the 14 cases with
SqLOH. and its upper and lower limits are described by cases
AT18 and ATl.
Chromosome 5 LOH in paraffin-embedded adenomas
We then screened five adenoma samples for allelic losses at three
specific regions of chromosome 5. including the two SCDRs
described by frozen samples and the APC locus. Four of the five
adenomas showed chromosome 5q LOH. Two adenomas showed
losses at only one region. They were pATl and pATl with loss of
APC gene mutations
The results of APC gene mutations in 15 cases have been previ-
ousy reported (Achille et al. 1996b). Of the seven additional cases
with available frozen tissues. only one (ATl9) showed an APC
truncated product at PTT test. whereas the remaining six cases
scored negative at both PTV and SSCP analyses (data not shown).
DISCUSSION
The detection in repeated experiments of a decreased intensity of
two AP-PCR bands assigned to chromosome S in 601% of tumours
of the papilla of Vater. together with the knowledge of a low
frequency ofAPC gene mutations in the same cases (Achille et al.
1996b). suggested to us that we screen our panel of ampullary
tumours in order to define the SCDRs on chromosome S.
Chromosome S allelotyping identified two SCDRs. different from
the APC locus. in which yet unknown suppressor genes might
reside. In addition. the results of our AP-PCR and allelotyping
experiments indicate that chromosome Sq LOH is a frequent event
(70%) in ampullary tumours and that it occurs at early stages of
neoplastic progression of ampullary epithelium. Moreover. the
finding of an increased intensity of AP-PCR band A in two cancer
DNAs also suggests that the anomalies of chromosome 5 in these
tumours may include the presence of extra copies of these
sequences. which could be due to gene amplification or tumour
aneuploidy (Peimado et al. 1992).
The analysis of 16 markers distributed along chromosome 5
using high-quality DNA from 22 ampullary tumours showed that
chromosome 5 LOH always involved the long arm ofthe chromo-
some, whereas the short arm was only lost in four cases and
always in conjunction with large chromosomal losses. Of these
four cases. cancers AT2 and ATS apparently had a reduction to
monosomy for chromosome 5. whereas case ATl had lost most of
the chromosome with retention of heterozygosity at the 5q21
locus. possibly because of an unbalanced complex translocation.
The majority of our cases showed interstitial losses. and overlap-
ping of their deletions described two SCDR regions. The first
SCDR corresponds to chromosomal bands 5ql3.3-ql4. The
second includes IRFI and FBN2 loci and spans the region
5q23-q3 1.
Little is known about the genetic events either initiating or
occurring in the early stages of ampullary tumorigenesis. Our
earlier studies suggested that APC and/or ras gene mutations are
likely to represent early pathogenetic events in only about 30%7 of
sporadic ampullary cancers, and that these tumours may progress
into high-grade. aggressive cancers by acquiring additional
genetic abnormalities. frequently including pS3 gene mutations
and allelic losses (Scarpa et al. 1993a.b: Achille et al. 1996b).
However. in most ampullary cancers, also frequently associated
with p53 gene mutations. the early gene alterations do not involve
ras orAPC abnormalities. Our present finding of a high frequency
of Sq LOH in ampullary cancers and the fact that these were
already present in six of eight adenomas suggest that such
phenomena occur at early stages of neoplastic transformation in a
high proportion of cases. The critical event associated with Sq
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LOH is the complete inactivation ofAPC function by mutation of
one allele and the loss of the other in about 15% of cases. such as
in adenoma AT17 and cancers AT14 and AT19. On the other hand.
the absence of APC mutations in the majority of cases and the
finding of two SCDRs at regions different from 5q21 suggest that
tumour-suppressor genes other than APC might be involved.
The presence of a tumour-suppressor gene different from APC
on chromosome Sq is suggested by several lines of evidence,
including the detection of frequent Sq deletions by either cyto-
genetic or molecular techniques in different types ofneoplasm. In
particular. fine mapping of chromosome Sq losses identified the
same two SCDRs described by ourcases in gastric cancer (Tamura
et al. 1996), and the 5q23-q31 SCDR in oesophageal carcinomas
(Ogasawara et al, 1996). In addition, the 5q13.3-q14 SCDR has
also been found in ovarian, lung and male germ tumours (Murty et
al. 1996: Tavassoli et al. 1996: Wieland et al, 1996), whereas the
5q23-q31 SCDR has also been described in acute myelogenous
leukaemia and myelodysplastic syndrome, in which deletions are
centred at band 5q31 (Horrigan et al, 1996). In this region, and
precisely to 5q31.1. the IRF-1 gene has been identified as a
possible candidate tumour-suppressor gene (Willman et al, 1993).
as it was able to revert the oncogenic transformation of the
NIH3T3 cell line induced by IRF-2 overexpression (Harada et al.
1993). However, other genes that locate near IRF-1. such as the
cytokine genes IL-3. IL-4. IL-S. GM-CSF and the mitotic inducer
CDC25C gene may be the target of5q31 LOH.
Ampullary cancer is an uncommon disease. Yet. it accounts for
about 36% of pancreaticoduodenal surgical demolitions. and the
decision as to whether it should be viewed as agastrointestinal oras
a peripancreatic cancer. together with biliary tract tumours. is
unclear (Brennan. 1990; Klempnauer et al, 1995: Rose et al. 1996).
This is not only a theoretical question. as it also involves debate
about use of surgical and/or chemotherapeutic treatment. Our
present data in conjunction with previous studies on ras and APC
mutations and microsatellite instability (Scarpa et al. 1993b. 1994;
Achille et al. 1996b. 1997). give further support to the view that the
molecular pathogenesis ofampullary cancers is more similar to that
of gastric cancers than to that of pancreatic cancers (McKie et al.
1993; Seymour et al. 1994; Tamura et al, 1994; Yashima et al.
1994). by also showing a similar frequency ofchromosome 5 LOH
and overlapping SCDRs (Tamura et al. 1996). The similarity of
ampullary cancers with gastric malignancies and their difference
from pancreatic cancers also encompasses the clinical behaviour. as
suggested by two studies (Brennan. 1990; Klempnauer et al. 1995).
ABBREVIATIONS
APC. adenomatous polyposis coli gene: LOH. loss of heterozy-
gosity: PCR. polymerase chain reaction: PTT. protein truncation
test; AP-PCR. arbitrarily primed-polymerase chain reaction:
SHARP. simultaneous hybridization of arbitrarily primed
PCR fingerprinting products; SSCP. single-strand conformation
polymorphism.
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